Society for Endocrinology - a world-leading authority on hormones

Press

09 Oct 2018


Too much vitamin A may increase risk of bone fractures


Consuming too much vitamin A may decrease bone thickness, leading to weak and fracture prone bones, according to a study published in the Journal of Endocrinology. The study, undertaken in mice, found that sustained intake of vitamin A, at levels equivalent to 4.5-13 times the human recommended daily allowance (RDA), caused significant weakening of the bones, and suggests that people should be cautious of over-supplementing vitamin A in their diets.

Vitamin A is an essential vitamin that is important for numerous biological processes including growth, vision, immunity and organ function.  Our bodies are unable to make vitamin A but a healthy diet including meat, dairy products and vegetables should be sufficient to maintain the body’s nutritional needs. Some evidence has suggested that people who take vitamin A supplements may be increasing their risk of bone damage. Previous studies in mice have shown that short-term overdosing of vitamin A, at the equivalent of 13-142 times the recommended daily allowance in people, results in decreased bone thickness and an increased fracture risk after just 1-2 weeks. This study is the first to examine the effects of lower vitamin A doses that are more equivalent to those consumed by people taking supplements, over longer time-periods. 

In this study, Dr Ulf Lerner and colleagues from Sahlgrenska Academy at the University of Gothenburg, report that mice given lower doses of vitamin A, equivalent to 4.5-13 times the RDA in humans, over a longer time period, also showed thinning of their bones after just 8 days, which progressed over the ten week study period.

Dr Ulf Lerner commented, “Previous studies in rodents have shown that vitamin A decreases bone thickness but these studies were performed with very high doses of vitamin A, over a short period of time. In our study we have shown that much lower concentrations of vitamin A, a range more relevant for humans, still decreases rodent bone thickness and strength.”

Next, Dr Ulf Lerner intends to investigate if human-relevant doses of vitamin A affect bone growth induced by exercise, which was not addressed in this study. Additionally, his team will study the effects of vitamin A supplementation in older mice, where growth of the skeleton has ceased, as is seen in the elderly.

Dr Ulf Lerner cautions: “Overconsumption of vitamin A may be an increasing problem as many more people now take vitamin supplements. Overdose of vitamin A could be increasing the risk of bone weakening disorders in humans but more studies are needed to investigate this. In the majority of cases, a balanced diet is perfectly sufficient to maintain the body’s nutritional needs for vitamin A.”


The paper “Clinically relevant doses of vitamin A decrease cortical bone mass in mice” was published in the Journal of Endocrinology in October 2018. 

The Journal of Endocrinology is published by Bioscientifica, an innovative and agile publisher. Bioscientifica collaborates with learned societies worldwide to develop new and existing quality products that meet the ever-changing needs of the biomedical community. Our publishing portfolio includes journals and online resources, including Journal of Endocrinology, Endocrine-Related Cancer, Journal of Molecular Endocrinology, Bone Abstracts and Endocrinology, Diabetes & Metabolism Case Reports. Bioscientifica is a wholly-owned commercial subsidiary of the Society for Endocrinology.

The Society for Endocrinology is a UK-based membership organisation representing a global community of scientists, clinicians and nurses who work with hormones. Together we aim to improve public health by advancing endocrine education and research, and engaging wider audiences with the science of hormones. 

Contact the press office

Recent press releases

Endocrinology in the news